NATIONAL RESEARCH CORP recently released its 10-K report, providing a comprehensive overview of its business and financial performance. The company offers a range of subscription-based solutions that provide actionable information and analysis to healthcare organizations across various mission-critical elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. Additionally, it offers marketing experience solutions, patient and employee experience solutions, governance solutions, and an AI engine for Human Understanding.
In the Management’s Discussion and Analysis of Financial Condition and Results of Operations, the company highlights that its purpose is to humanize healthcare and support organizations in understanding each unique individual. It emphasizes the importance of its end-to-end solutions in enabling customers to understand what matters most to each person they serve.
The 10-K report also discusses critical accounting estimates, including revenue recognition. The report notes that the company derives the majority of its revenue from renewable subscription-based service agreements with customers and also derives revenue from fixed, non-subscription arrangements.
The report provides an overview of recent trends, indicating that Total Recurring Contract Value (TRCV) has increased each quarter since the fourth quarter of 2024. Additionally, the report mentions that the company made significant changes in senior management, developed and marketed innovative new products, and reconstituted a motivated sales force, which has led to improved financial performance.
Key financial metrics and results of operations are also detailed in the report. In 2025, the company reported a decrease in revenue compared to 2024, primarily due to decreased recurring revenue in its existing customer base. Direct expenses and selling, general, and administrative expenses are also discussed, with explanations for the changes in these expenses provided.
The report also discusses non-GAAP financial measures, including Adjusted Net Income, Adjusted Earnings per Share, Adjusted EBITDA, and Adjusted EBITDA Margin. These measures are presented as supplemental measures to assist management and investors in evaluating the company’s operating results.
As a result of these announcements, the company's shares have moved 4.32% on the market, and are now trading at a price of $22.22. If you want to know more, read the company's complete 10-K report here.
